Welcome

Sign out Have a question? We're here to help

Copyright © 2019 InvestorPlace Media, LLC. All rights reserved. 9201 Corporate Blvd, Rockville, MD 20850.

Macrogenics (MGNX)

$13.01 0.07 (0.57%)

11:46 EDT MGNX Stock Quote Delayed 15 Minutes

Volume:

Previous Close $13.08

Market Cap 548.84M

PE Ratio -16.26

EPS -0.8

Volume (Avg. Vol.) 201,986

Day's Range 12.86 - 13.32

52-Week Range 9.87 - 32.32

Dividend & Yield N/A (N/A)

MGNX Stock Predictions, Articles, and Macrogenics News

From InvestorPlace
From the Web

Why MacroGenics Stock Is Soaring Today

By John Kilhefner, Managing Editor, InvestorPlace.com Feb 6, 2019

MacroGenics Inc (MGNX) is surging today after solid Phase-III trial results on its later-stage breast cancer treatment. Should you buy MGNX stock?

athenahealth, Inc (ATHN), Yelp Inc (YELP) Leads Today’s Top 30 Investor Filings

By Fintel Jun 13, 2017

13D and 13G filings are windows into activist investor activity. Today's focus in on athenahealth, Inc. and Yelp among 30 new filings

SLCA, PK, LXRX and ADVM among notable after hours movers

From Seeking Alpha Sep 12, 2019

Top Gainers: VNCE +20.3%. DRAD +12.7%. MGNX +5%. ADVM +4%. PK +3.7%.Top Losers: SLCA -6%. LXRX -3.3%. CARS -2.8%. AZUL -2.3%.

Notable Thursday Option Activity: MGNX, MTZ, BBY

From Market News Video Aug 1, 2019

Looking at options trading activity among components of the Russell 3000 index, there is noteworthy activity today in MacroGenics, Inc (MGNX), where a total volume of 3,449 contracts has been traded thus far today, a contract volume which is representative of approximately 344,900 underlying shares (given that every 1 contract represents 100 underlying shares). That number works out to 80.8% of MGNX's average daily trading volume over the past month, of 427,080 shares..

Analysts’ Top Healthcare Picks: Amarin (AMRN), MacroGenics (MGNX)

From Smarter Analyst Aug 1, 2019

There's a lot to be optimistic about in the Healthcare sector as 3 analysts just weighed in on Amarin (AMRN), MacroGenics (MGNX) and Omeros Corp (OMER)

Analysts’ Top Healthcare Picks: Amarin (AMRN), MacroGenics (MGNX)

From Analyst Ratings Aug 1, 2019

There’s a lot to be optimistic about in the Healthcare sector as 3 analysts just weighed in on Amarin (AMRN – Research Report), MacroGenics (MGNX – Research Report) and Omeros Corp (OMER – Research Report) with bullish sentiments. Amarin (AMRN) In a report released today, Andrew Fein from H.C. Wainwright reiterated a Buy rating on

MacroGenics (MGNX) Receives a Buy from Cowen & Co.

From Smarter Analyst Aug 1, 2019

Cowen & Co. analyst Boris Peaker maintained a Buy rating on MacroGenics (MGNX) today. The company's shares closed yesterday at $14.39. According to

The Daily Biotech Pulse: Roche-Spark Deal Faces Further Delay, Bayer's Prostate Cancer Drug Passes FDA Muster

From Benzinga Jul 31, 2019

Here's a roundup of top developments in the biotech space over the last 24 hours. Scaling The Peaks (Biotech stocks hitting 52-week highs on July 30) Acasti Pharma Inc (...

Navellier Ratings

Powered by Portfolio Grader

Total Grade

C

Hold

Free Report

10 Stocks Set for Monster Growth

He found Apple at $4… Oracle at $6… Amazon at $40… Now legendary growth investor Louis Navellier is giving away his latest Research Report — for FREE!

Download your FREE COPY!